Masucci, Luca
 Distribuzione geografica
Continente #
EU - Europa 2.630
NA - Nord America 2.537
AS - Asia 1.219
SA - Sud America 241
AF - Africa 28
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.670
Nazione #
US - Stati Uniti d'America 2.496
IT - Italia 576
SE - Svezia 500
DE - Germania 497
SG - Singapore 473
CN - Cina 400
PL - Polonia 235
BR - Brasile 217
FR - Francia 207
IE - Irlanda 147
UA - Ucraina 102
FI - Finlandia 82
GB - Regno Unito 82
ID - Indonesia 82
IN - India 72
RU - Federazione Russa 52
KR - Corea 37
TR - Turchia 32
AT - Austria 29
CA - Canada 28
BE - Belgio 26
NL - Olanda 26
HK - Hong Kong 23
CZ - Repubblica Ceca 17
AU - Australia 14
CH - Svizzera 11
IR - Iran 11
LT - Lituania 10
VN - Vietnam 10
ES - Italia 9
JP - Giappone 9
PH - Filippine 9
MA - Marocco 8
BD - Bangladesh 7
TW - Taiwan 7
EC - Ecuador 6
GR - Grecia 6
MX - Messico 6
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
CY - Cipro 5
PE - Perù 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
PK - Pakistan 4
ZA - Sudafrica 4
CO - Colombia 3
EG - Egitto 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
NG - Nigeria 3
NO - Norvegia 3
TH - Thailandia 3
UZ - Uzbekistan 3
BY - Bielorussia 2
CL - Cile 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HN - Honduras 2
JO - Giordania 2
NP - Nepal 2
RO - Romania 2
TN - Tunisia 2
AL - Albania 1
BO - Bolivia 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TZ - Tanzania 1
UY - Uruguay 1
VE - Venezuela 1
Totale 6.670
Città #
Chandler 441
Singapore 293
Warsaw 221
Ashburn 195
Dublin 145
Ann Arbor 116
Rome 95
Fairfield 83
Jacksonville 81
Jakarta 80
Milan 74
New York 73
Wilmington 69
Woodbridge 69
San Mateo 61
Boston 54
Dearborn 54
Marseille 54
Chicago 51
Beijing 47
Los Angeles 47
Nanjing 47
Princeton 43
Cattolica 41
Moscow 38
Houston 37
Seoul 37
Seattle 35
Helsinki 34
Munich 34
Redwood City 30
Hefei 29
Izmir 25
Pune 25
The Dalles 24
Boardman 23
Nürnberg 22
Frankfurt am Main 21
Lawrence 21
Brussels 20
Nuremberg 20
Cambridge 19
London 19
Turku 19
Zhengzhou 19
Hangzhou 18
Hong Kong 18
Redmond 18
Falkenstein 17
Vienna 17
Düsseldorf 16
Nanchang 16
North Bergen 14
São Paulo 14
Augusta 13
Falls Church 13
Kunming 13
Paris 13
Hebei 11
Hyderabad 11
Melbourne 11
Mountain View 11
Norwalk 11
Shanghai 11
Shenyang 11
Tianjin 11
San Francisco 10
Stockholm 10
Toronto 10
Washington 10
Florence 8
Lancaster 8
Ottawa 8
Zurich 8
Guangzhou 7
Rio de Janeiro 7
Ceska 6
Council Bluffs 6
Fremont 6
Kaohsiung 6
Lauterbourg 6
Abidjan 5
Amsterdam 5
Baku 5
Bari 5
Bologna 5
Brno 5
Busto Arsizio 5
Campinas 5
Changsha 5
Dong Ket 5
Edinburgh 5
Genoa 5
Salt Lake City 5
University Park 5
Bolzano 4
Bremen 4
Cascina 4
Detroit 4
Dhaka 4
Totale 3.579
Nome #
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 408
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 212
The role of diet on gut microbiota composition 168
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 168
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 144
Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases 142
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 140
The effect of different antibiotic regimens on bacterial resistance: a systematic review 138
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 137
Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice 125
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 121
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 117
Polymerase chain reaction-reverse cross-blot hybridization assay in the diagnosis of sporotrichoid Mycobacterium marinum infection 114
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm 112
Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection. 110
Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates 109
Entamoeba dispar: A Rare Case of Enteritis in a Patient Living in a Nonendemic Area 109
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 105
European consensus conference on faecal microbiota transplantation in clinical practice 102
A patient with acute myeloid leukemia and a solid mass in the colon. 101
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection 99
In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates. 96
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 95
Multiple malaria infection in a pregnant woman from Nigeria: detection by multiplex PCR 93
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: a pre-post analysis in a Third Level Referral Center 93
Whole-genome sequencing reveals host factors underlying critical COVID-19 92
Intestinal Parasitic Infections in Internationally Adopted Children: A 10-Year Retrospective Study 91
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 91
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 85
Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016 85
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 85
Reply to Seligman 80
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 75
An explainable model of host genetic interactions linked to COVID-19 severity 74
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 73
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 71
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 71
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 68
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 68
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 66
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 65
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 64
Conjonctival papilloma and human papillomavirus: identification of HPV types by PCR. 63
Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study 63
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss 62
Characterizing peri-implant and sub-gingival microbiota through culturomics. First isolation of some species in the oral cavity. A pilot study 62
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 61
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 61
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 60
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 59
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 58
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 57
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 56
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial 56
Laboratory handling practice for faecal microbiota transplantation 56
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 53
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 52
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 52
SARS-CoV-2 vaccines and donor recruitment for FMT 50
PCR-reverse cross blot hybridization assay as an useful diagnostic tool in a case of Mycobacterium marinum sporotrichoid infection 48
The Italian national faecal microbiota transplantation program: A coordinated effort against Clostridioides difficile infection 48
Laboratory handling practice for faecal microbiota transplantation 48
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 47
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 46
Fecal microbiota transplantation: What’s new? 45
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 45
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 45
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 44
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 44
How the gut parasitome affects human health 42
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions 41
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies 40
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 40
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 40
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes 39
A literature review of metagenomics and culturomics of the peri-implant microbiome: Current evidence and future perspectives 39
Culturomic and quantitative real-time-polymerase chain reaction analyses for early contamination of abutments with different surfaces: A randomized clinical trial 37
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel 34
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel 32
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 31
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 28
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 26
Genetic mechanisms of critical illness in COVID-19 26
comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis 25
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 25
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 24
International consensus statement on microbiome testing in clinical practice 20
Mapping the human genetic architecture of COVID-19 20
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 20
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 19
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 16
Clinical and molecular characterization of COVID-19 hospitalized patients 14
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 11
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 9
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone 6
Totale 6.807
Categoria #
all - tutte 35.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202051 0 0 0 0 0 0 0 0 0 0 0 51
2020/2021491 43 62 15 42 67 43 62 8 54 21 63 11
2021/2022611 69 27 18 29 35 27 10 68 34 34 155 105
2022/20231.475 195 176 90 155 104 165 89 127 194 95 53 32
2023/2024943 59 225 39 66 44 146 77 25 19 50 93 100
2024/20251.724 39 70 135 110 156 72 97 79 260 228 402 76
Totale 6.807